Atai Life Sciences Operating Expenses 2020-2025 | ATAI

Atai Life Sciences operating expenses from 2020 to 2025. Operating expenses can be defined as the sum of all operating expenses for the given industry.
Atai Life Sciences Annual Operating Expenses
(Millions of US $)
2024 $103
2023 $126
2022 $145
2021 $156
2020 $104
2019 $18
Atai Life Sciences Quarterly Operating Expenses
(Millions of US $)
2025-03-31 $22
2024-12-31 $30
2024-09-30 $23
2024-06-30 $26
2024-03-31 $24
2023-12-31 $34
2023-09-30 $27
2023-06-30 $32
2023-03-31 $33
2022-12-31 $38
2022-09-30 $38
2022-06-30 $36
2022-03-31 $33
2021-12-31 $45
2021-09-30 $34
2021-06-30 $61
2021-03-31 $16
2020-12-31 $87
2020-09-30 $7
2020-06-30 $6
2020-03-31 $4
2019-12-31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.369B $0.000B
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.885B 19.59
Encompass Health (EHC) United States $12.215B 25.89
DaVita (DVA) United States $10.944B 15.39
Chemed (CHE) United States $8.456B 26.58
Elanco Animal Health (ELAN) United States $6.566B 14.06
Option Care Health (OPCH) United States $5.418B 24.15
RadNet (RDNT) United States $4.551B 288.86
Amedisys (AMED) United States $3.089B 20.78
LifeStance Health (LFST) United States $2.271B 0.00
Addus HomeCare (ADUS) United States $2.044B 22.44
Astrana Health (ASTH) United States $1.505B 37.29
U.S Physical Therapy (USPH) United States $1.211B 31.26
Aveanna Healthcare Holdings (AVAH) United States $1.112B 63.33
Pennant (PNTG) United States $1.025B 37.65
Daxor (DXR) United States $0.037B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.022B 0.00
Ontrak (OTRK) United States $0.007B 0.00
Psychemedics (PMD) United States $0.000B 0.00